Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:576486.
doi: 10.1155/2013/576486. Epub 2013 Jul 9.

Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer

Adam Antczak  1 , Dorota Pastuszak-Lewandoska, Paweł Górski, Daria Domańska, Monika Migdalska-Sęk, Karolina Czarnecka, Ewa Nawrot, Jacek Kordiak, Ewa Brzeziańska
Affiliations

Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer

Adam Antczak et al. Biomed Res Int. 2013.

Abstract

Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is a potent immunoregulatory molecule that downregulates T-cell activation and thus influences the antitumor immune response. CTLA-4 polymorphisms are associated with various cancers, and CTLA-4 mRNA/protein increased expression is found in several tumor types. However, most of the studies are based on peripheral blood mononuclear cells, and much less is known about the relationship between CTLA-4 expression, especially gene expression, and its polymorphic variants in cancer tissue. In our study we assessed the distribution of CTLA-4 two polymorphisms (+49A/G and -318C/T), using TaqMan probes (rs231775 and rs5742909, resp.), and CTLA-4 gene expression in real-time PCR assay in non-small-cell lung cancer (NSCLC) tissue samples. The increased CTLA-4 expression was observed in the majority of NSCLC patients, and it was significantly correlated with TT genotype (-318C/T) and with tumor size (T2 versus T3 + T4). The presence of G allele and GG genotype in cancer tissue (+49A/G) was significantly associated with the increased NSCLC risk. Additionally, we compared genotype distributions in the corresponding tumor and blood samples and found statistically significant differences. The shift from one genotype in the blood to another in the tumor may confirm the complexity of gene functionality in cancer tissue.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chew V, Toh HC, Abastado JP. Immune microenvironment in tumor progression: characteristics and challenges for therapy. Journal of Oncology. 2012;2012:608406–608415. - PMC - PubMed
    1. Tsiatas ML, Gyftaki R, Liacos C, et al. Study of T lymphocytes infiltrating peritoneal metastases in advanced ovarian cancer associations with vascular endothelial growth factor levels and prognosis in patients receiving platinum-based chemotherapy. International Journal of Gynecological Cancer. 2009;19(8):1329–1334. - PubMed
    1. Frey AB, Monu N. Signaling defects in anti-tumor T cells. Immunological Reviews. 2008;222(1):192–205. - PMC - PubMed
    1. Sharpe AH, Abbas AK. T-cell costimulation—biology, therapeutic potential, and challenges. The New England Journal of Medicine. 2006;355(10):973–975. - PubMed
    1. Nagorsen D, Scheibenbogen C, Marincola FM, Letsch A, Keilholz U. Natural T cell immunity against cancer. Clinical Cancer Research. 2003;9(12):4296–4303. - PubMed

MeSH terms

Substances

LinkOut - more resources